The American Journal of Preventive Medicine (November 3 ,2013) reviewed a number of studies linking the usefulness of PSA screening to prostate cancer. This is important because the government has suggested that there is limited or no benefits to this test. However there were many studies that DID show a connection and benefit to PSA screening. Since ambiguity exists, our recommendation is to continue with yearly PSA screenings for men at risk. It is more important how we interpret the test rather than lump everyone into one unified group (the old “shades of gray rather than black or white).